J&J | Créanciers Commerciaux



Trade Creditors Changement Date
AbbVie 2.94B 2.66B 2024-12
Abbott USD 4.21B 7.48B 2025-03
Amgen USD 2.41B 498M 2025-03
AstraZeneca 22.54B 79M 2025-03
Baxter International USD 968M 127M 2024-12
Bayer EUR 6.59B 931M 2025-03
Becton, Dickinson and Co. USD 1.9B 255M 2024-09
Biogen USD 391.5M 32.7M 2025-03
Boston Scientific USD 1B 44M 2025-03
Bristol-Myers Squibb USD 4B 400M 2025-03
CONMED USD 95.73M 6.52M 2025-03
Cooper Companies USD 201.5M 59M 2025-01
Dexcom USD 432M 86.7M 2025-03
Edwards Lifesciences USD 197.4M 24.6M 2024-12
Eli Lilly USD 3.44B 213.4M 2025-03
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.15B 186M 2025-03
Globus Medical USD 73.14M 1.97M 2025-03
Hologic USD 208.6M 28.1M 2025-03
Indivior 183M 120M 2025-03
Insulet USD 57.6M 37.8M 2025-03
Integra LifeSciences USD 91.3M 8.79M 2025-03
Intuitive Surgical USD 276.2M 82.8M 2025-03
J&J USD 9.54B 766M 2025-03
Medtronic USD 2.45B 163M 2025-04
Merck USD 3.78B 295M 2025-03
Merit Medical Systems USD 63.76M 4.74M 2025-03
Novartis USD 4.57B 485M 2024-12
Pfizer USD 5.24B 393M 2025-03
Regeneron Pharmaceuticals USD 705.5M 4.18B 2025-03
Roche Holding 4.35B 828M 2024-12
Sanofi 21.62B 14.07B 2025-03
Stryker USD 1.46B 215M 2025-03
Tandem Diabetes Care USD 59.8M 15.07M 2025-03
Teva Pharmaceutical Industries USD 2.29B 87M 2025-03
Vertex Pharmaceuticals USD 413M 17.2M 2024-12
Zimmer Biomet Holdings USD 194.6M 127.8M 2024-12
Zoetis USD 420M 13M 2025-03



J&J Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.